Enthorin Therapeutics
PrivateCompany Overview
Enthorin Therapeutics is a biotechnology company that develops circuit-modulating treatments for neurological and neurodevelopmental disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
biotechnologydrug discoveryCNS therapeuticsPDE inhibitorneurodevelopmental disordersbiotech startupclinical-stage pharmaneural plasticitydrug licensingsmall molecule therapeuticsneuroscience researchpharma pipelinetranslational neurobiologyGABA modulatordrug development
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enthorin Therapeutics Comparables
Compare Enthorin Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kaerus Bioscience | 82% | |
| Connecta Therapeutics | 81% | |
| Shionogi & Co. | 81% | |
Enthorin Therapeutics Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Enthorin Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Enthorin Therapeutics's valuation, stock price, and market status.
Firmographic Details
HeadquartersEscondido, California
Employee Range2
Year Founded2020
Last Funding—